About OncoGenex

test

ONCOGENEX ANNOUNCES INITIATION OF RANDOMIZED PHASE 2 "Pacific" STUDY OF OGX-427 WITH ZYTIGA® FOR PATIENTS WITH ADVANCED PROSTATE CANCER

Read more here.

External Link Pop Up Window

You are now exiting the OncoGenex Web site and entering a third party Web site.

OncoGenex does not review the information contained on the following Web site for content, accuracy or completeness. Use of and access to the information are subject to the terms, limitations and conditions set by the Web site producer. OncoGenex makes no claims about the accuracy or any other aspect of the information contained on this Web site, nor does OncoGenex necessarily endorse this Web site.

Stay on OncoGenex Continue